colforsin has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brownlow, RC; Butterworth, JF; Cole, LR; Leith, JP; Prielipp, RC | 1 |
| Alleva, FR; Balazs, T; Joseph, X; Vick, JA; Whitehurst, VE; Zhang, J | 1 |
| Niaz, MA; Singh, RB | 1 |
4 other study(ies) available for colforsin and Cardiovascular Diseases
| Article | Year |
|---|---|
Coleus forskohlii. Monograph.
Topics: Adenosine Monophosphate; Cardiovascular Diseases; Coleus; Colforsin; Glaucoma; Hypersensitivity; Obesity; Platelet Activating Factor; Psoriasis | 2006 |
Bupivacaine inhibits cyclic-3',5'-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity.
Topics: Adenylyl Cyclases; Adult; Amides; Bupivacaine; Cardiovascular Diseases; Colforsin; Cyclic AMP; Drug Interactions; Enzyme Activation; Epinephrine; Female; GTP-Binding Proteins; Humans; Kinetics; Lymphocytes; Male; Mepivacaine; Middle Aged; Models, Biological; Receptors, Adrenergic, beta; Ropivacaine; Signal Transduction; Stimulation, Chemical | 1993 |
Reversal of propranolol blockade of adrenergic receptors and related toxicity with drugs that increase cyclic AMP.
Topics: Adenylyl Cyclases; Adrenergic Antagonists; Aminophylline; Amrinone; Animals; Blood Pressure; Cardiovascular Diseases; Colforsin; Cyclic AMP; Dogs; Enzyme Activation; Heart Rate; Myocardium; Phosphodiesterase Inhibitors; Propranolol; Respiration | 1999 |
Modulation of free radical stress in human red blood cell membrane by forskolin and the prospects for treatment of cardiovascular disease and diabetes.
Topics: Antioxidants; Cardiovascular Diseases; Cell Membrane; Colforsin; Diabetes Mellitus; Erythrocytes; Free Radicals; Glucose; Humans; In Vitro Techniques; Lipid Peroxidation; Oxidative Stress | 1999 |